Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ocular Sciences was a prominent manufacturer of soft contact lenses, specializing in products for the independent eye care professional market. The company's portfolio included a wide array of disposable, frequent replacement, and specialty lenses, such as toric and multifocal options. It was recognized for its proprietary cast-molding manufacturing process, which allowed for high-volume production of high-quality lenses. In 2004, Ocular Sciences was acquired by CooperCompanies for approximately $1.2 billion. Following the acquisition, its operations were integrated into CooperVision, significantly expanding the latter's global market share.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ocular Sciences.